A 67‑year‑old man with COPD has ≥2 moderate exacerbations last year and mMRC 3 dyspnoea (Group E). Eosinophils 180/µL. Which initial inhaled regimen i...

Question

A 67‑year‑old man with COPD has ≥2 moderate exacerbations last year and mMRC 3 dyspnoea (Group E). Eosinophils 180/µL. Which initial inhaled regimen is recommended?

Accepted Answer

LAMA + LABA

Answer

SABA only as needed

Answer

LABA monotherapy

Answer

LABA + ICS

Answer

Triple therapy LABA + LAMA + ICS regardless of eosinophils

us-abfm MCQ (SBA): COPD

A 67‑year‑old man with COPD has ≥2 moderate exacerbations last year and mMRC 3 dyspnoea (Group E). Eosinophils 180/µL. Which initial inhaled regimen is recommended?